Discover the role of phytoestrogens, including soy, in menopause management and breast cancer prevention. Learn how these ...

Excluding people with type 2 diabetes from the trial might have resulted in a missed opportunity to establish whether people with both Parkinson's disease and type 2 diabetes could benefit from GLP-1 ...

Data is presented as mean ± SEM (standard error of the mean). Cumulative food intake (as percent of body weight) was analyzed by repeated measure two-way analysis of ...

Department of Pharmacology and Computational Medicine Program, University of North Carolina−Chapel Hill, Chapel Hill, North Carolina 27599, United States ...

HealthDay News — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for thyroid cancer over the short term, according to a study published online Jan. 16 ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Of those, over 215,000 had been prescribed a glucagon-like peptide-1 (GLP-1) agonist receptor — the class of drugs that includes Ozempic, Wegovy, Mounjaro, Zepbound, and others — and 1.7 ...

If you're one of the 37 million Americans who get migraine headaches, you know these painful headaches can make you miss work or school and can last several days if they're not treated. In some ...

On the other hand, the fact that receptors for GLP1 are present on subsets of immune cells means that until we have deeper knowledge, the effects of these drugs on inflammatory responses are somewhat ...